World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
50
Citations
10465
World Ranking
2555
National Ranking
5

Jan Trka publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Jan Trka sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 237 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Jan Trka D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Jan Trka sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 50 D-Index — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Jan Trka is affiliated with Charles University in the Czech Republic and has a research focus spanning Medicine, Biochemistry, Genetics, and Molecular Biology. Their work covers several subfields including Public Health, Environmental and Occupational Health, Hematology, Molecular Biology, Genetics, and Pediatrics, Perinatology and Child Health.

Their research topics primarily emphasize Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, and Chronic Myeloid Leukemia Treatments. Other significant areas include Childhood Cancer Survivors' Quality of Life, Chronic Lymphocytic Leukemia Research, Cancer Genomics and Diagnostics, and Lymphoma Diagnosis and Treatment.

Frequent coauthors collaborating with Jan Trka include Markéta Žaliová, Jan Starý, Jan Zuna, Eva Froňková, and Lucie Šrámková. Their publications have appeared predominantly in the journals Blood, Leukemia, HemaSphere, Haematologica, and Blood Advances.

Notable recent papers authored or coauthored by Jan Trka highlight various aspects of leukemia research:

  • "The KMT2A recombinome of acute leukemias in 2023" (2023, Leukemia)
  • "DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch" (2020, Haematologica)
  • "Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease" (2022, Leukemia)
  • "The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age" (2023, HemaSphere)
  • "NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol" (2022, Blood)

Best Publications

  • Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

    V H J van der Velden;G Cazzaniga;A Schrauder;J Hancock

  • The MLL recombinome of acute leukemias in 2017

    C Meyer;T Burmeister;D Gröger;G Tsaur

  • The MLL recombinome of acute leukemias in 2013

    C. Meyer;J. Hofmann;T. Burmeister;D. Gröger

  • New insights to the MLL recombinome of acute leukemias

    C. Meyer;E. Kowarz;J. Hofmann;A. Renneville

  • Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

    Dani Bercovich;Ithamar Ganmore;Linda M. Scott;Gilad Wainreb

  • Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002

    Jan Stary;Martin Zimmermann;Myriam Campbell;Luis Castillo

  • Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia

    Prisca Theunissen;Ester Mejstrikova;Lukasz Sedek;Alita J. van der Sluijs-Gelling

  • NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.

    Iris H.I.M. Hollink;Marry M. van den Heuvel-Eibrink;Susan T.C.J.M. Arentsen-Peters;Marta Pratcorona

  • Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.

    Liat Rainis;Dan Bercovich;Sabine Strehl;Andrea Teigler-Schlegel

  • The MLL recombinome of acute leukemias.

    C. Meyer;B. Schneider;S. Jakob;S. Strehl

  • Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study

    Monika Brüggemann;Michaela Kotrová;Henrik Knecht;Jack Bartram

  • NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.

    J D E de Rooij;I H I M Hollink;S T C J M Arentsen-Peters;J F van Galen

  • IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL

    Arian van der Veer;Marketa Zaliova;Marketa Zaliova;Federica Mottadelli;Paola De Lorenzo

  • Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia.

    Iris H. I. M. Hollink;Marry M. van den Heuvel-Eibrink;Martin Zimmermann;Brian V. Balgobind

  • BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations

    Anindita Basak;Miroslava Hancarova;Jacob C. Ulirsch;Tugce B. Balci

  • Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry.

    J Trka;M Kalinová;O Hrusák;J Zuna

  • Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia

    Lucie Sramkova;Katerina Muzikova;Eva Fronkova;Ondrej Krejci

  • Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia.

    Brian V. Balgobind;Marry M. Van den Heuvel-Eibrink;Renee X. De Menezes;Dirk Reinhardt

  • Identification of germline susceptibility loci in ETV6 - RUNX1 -rearranged childhood acute lymphoblastic leukemia

    E Ellinghaus;M Stanulla;G Richter;D Ellinghaus

  • Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53

    Nir Gefen;Vera Binder;Vera Binder;Marketa Zaliova;Yvonne Linka

Frequent Co-Authors

Rob Pieters
Rob Pieters Princess Máxima Center
Dirk Reinhardt
Dirk Reinhardt University of Duisburg-Essen
Martin Zimmermann
Martin Zimmermann Hannover Medical School
Marry M. van den Heuvel-Eibrink
Marry M. van den Heuvel-Eibrink University Medical Center Utrecht
Martin Stanulla
Martin Stanulla Hannover Medical School
Rolf Marschalek
Rolf Marschalek Goethe University Frankfurt
Giovanni Cazzaniga
Giovanni Cazzaniga University of Milano-Bicocca
Martin Schrappe
Martin Schrappe Kiel University
André Baruchel
André Baruchel Hôpital Robert-Debré

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Molecular Biology can open the door to many interdisciplinary career paths, especially when paired with online learning options. Students from non-traditional backgrounds are increasingly choosing programs that help them bridge the gap into healthcare and life sciences roles.

For example, if you have a background in communication sciences but are interested in moving toward clinical practice, speech pathology bridge programs online are a popular and flexible way to qualify for licensure. Similarly, individuals without a nursing degree can take advantage of accelerated nursing programs for non nurses online, allowing a faster track into the nursing profession.

Advanced practice roles are also accessible online. Many aspiring professionals want to know how long does it take to be a nurse practitioner, as these programs offer a combination of convenience and career advancement. For those considering specialized fields, understanding the earning potential—such as the dnp pmhnp salary—can further guide your education and career planning.

Best Scientists Citing Jan Trka

Trending Scientists

Recently Published Articles